RheumNow

25-Hydroxyvitamin D levels and Lupus Outcomes Lupus patients entering a prospective cohort study with low vitamin D lev https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… […]

A New Disease Activity Score for Antiphospholipid Syndrome? jjcush@gmail.com Thu, 11/20/2025 – 14:31

Organ Involvement with Behçet’s jjcush@gmail.com Thu, 11/20/2025 – 14:53

Serious infections w/ adalimumab. Marketscan MarketScan claims study (1/17-12/20) of ADA Rx in Hidradenitis Supprativa ( https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 11/20/2025

Seeking Musculoskeletal Care A report entitled The Burden of Musculoskeletal Diseases in the United States (BMUS) was https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,

ICYMI: Head-to-Head Clinical Trials https://t.co/LpvqQRP06b https://t.co/YkXYvUuJWx https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 11/20/2025 – 10:00 RheumNow Dr. John Cush ICYMI: Head-to-Head Clinical Trials

Retrospective review of 113 AOSD pts, median age 45yrs, ferritin 4626 (IQR 1169–14,239). Advanced Rx (IVIG, IL-1, IL- https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

APEX Study: Inhibition of structural damage progression with Guselkumab in Psoriatic Arthritis jjcush@gmail.com Wed, 11/19/2025 – 18:39

Lupus Nephritis study of 136 pts followed 121 mos. Median time to wean GC to 7.5 mg/day, 5 mg/day & D/C was

Pulse Steroids and Mycophenolate in Juvenile Dermatomyositis jjcush@gmail.com Wed, 11/19/2025 – 16:21

Review of neonatal Fc receptor (FcRn) blockers, being developed by J&J, argenx & UCB, showing utility in autoimm https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

NEW ONLINE ACR POSTER: 2-year efficacy and safety outcomes with a JAKi in patients with GCA Click to see the

Japanese ANSWER cohort (3623 RA pts on bDMARDs or JAKi) included looked at T2T in 118 RA pregnancies. 93% had

Serum IL-1Ra levels are elevated in Lg vessel vasculitis – 21 active, Rx naive LVV pts (13 GCA, 8 TAK),

Australian Vaccine study (2019 – 2021) – w/in 12 mos of b/tsDMARD initiation 73% (11,225/15,460) recv influenza vaccinat https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

Tuesday Nite Rheumatology (on 11.18.25) https://t.co/mTCJVmJwgn https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 11/18/2025 – 19:15 RheumNow Dr. John Cush Tuesday Nite Rheumatology (on

Rheumatology Supply and Demand (2009 – 2024) jjcush@gmail.com Tue, 11/18/2025 – 18:39

Seeking Musculoskeletal Care jjcush@gmail.com Tue, 11/18/2025 – 19:03

Metanalysis of 56 articles & 72,677 RA pts w/ a Dz duration of 9.7 yrs looked at biologic persistence. In csDMARD-

PROSPERO meta-analysis shows an effect of diet on #RA risk. 8 independent studies (n=270,121) showed a reduced risk of i

Treating During Pregnancy (11.14.2025) | RheumNow https://t.co/sTv7O6YcnA https://t.co/KT0qGFJu0O https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 11/18/2025 – 11:30 RheumNow Dr. John Cush Treating During

RNL 25 Replay: Rheumatoid Arthritis Enjoy these excerpts from the RNL 2025 meeting, and join us for RNL 2026 in

Postmenopausal women on estrogen hormone therapy (HT) had a modest incr risk (HR 1.33; 1.32-1.35; P < .001). of a

ACR Applauds Bipartisan Support for Prior Authorization Reform Bill jjcush@gmail.com Mon, 11/17/2025 – 19:14

Retrospective cohort study adult RA patients shows that TRIPLE Positivity (RF + /ACPA + /ANA +) was consisten https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 11/17/2025 – 18:57 RheumNow